D-Index & Metrics Best Publications
Jan M. Bell

Jan M. Bell

Boston Children's Hospital
United States

Overview

What is he best known for?

The fields of study he is best known for:

  • Bacteria
  • Antibiotics
  • Gene

Jan M. Bell spends much of his time researching Microbiology, Antibacterial agent, Antibiotics, Klebsiella pneumoniae and Drug resistance. Jan M. Bell studied Microbiology and Staphylococcus aureus that intersect with Antibiotic resistance. Jan M. Bell has researched Antibacterial agent in several fields, including Enterococcus faecalis and Genotype.

His studies examine the connections between Klebsiella pneumoniae and genetics, as well as such issues in Aztreonam, with regards to Outbreak and Virology. Vancomycin is closely connected to Multiple drug resistance in his research, which is encompassed under the umbrella topic of Antimicrobial. His studies in Broth microdilution integrate themes in fields like Acinetobacter baumannii and Carbapenem.

His most cited work include:

  • Survey of Infections Due to Staphylococcus Species: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999 (1128 citations)
  • Dissemination of New Methicillin-Resistant Staphylococcus aureus Clones in the Community (859 citations)
  • Early Dissemination of NDM-1- and OXA-181-Producing Enterobacteriaceae in Indian Hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 2006-2007 (290 citations)

What are the main themes of his work throughout his whole career to date?

Jan M. Bell mainly focuses on Microbiology, Antibacterial agent, Antimicrobial, Antibiotic resistance and Drug resistance. His Microbiology study combines topics in areas such as Vancomycin, Staphylococcus aureus and Klebsiella pneumoniae. His Antibacterial agent research integrates issues from Cefepime and Etest.

His work carried out in the field of Antimicrobial brings together such families of science as Clindamycin, Traditional medicine, Moraxella catarrhalis and Doripenem. His research in Antibiotic resistance intersects with topics in Ciprofloxacin, Erythromycin, Veterinary medicine, Trimethoprim and Ceftriaxone. Jan M. Bell works mostly in the field of Drug resistance, limiting it down to concerns involving Pulsed-field gel electrophoresis and, occasionally, Ribotyping.

He most often published in these fields:

  • Microbiology (82.14%)
  • Antibacterial agent (29.46%)
  • Antimicrobial (26.79%)

What were the highlights of his more recent work (between 2011-2016)?

  • Microbiology (82.14%)
  • Antibiotic resistance (25.00%)
  • Cephalosporin (7.14%)

In recent papers he was focusing on the following fields of study:

His main research concerns Microbiology, Antibiotic resistance, Cephalosporin, Ceftriaxone and Drug resistance. The study incorporates disciplines such as Staphylococcal infections, Staphylococcus aureus and Enterobacter cloacae in addition to Microbiology. Jan M. Bell usually deals with Staphylococcus aureus and limits it to topics linked to Antibacterial activity and Antibiotics.

His work deals with themes such as Vancomycin, Antimicrobial, Gentamicin and Fusidic acid, which intersect with Antibiotic resistance. His Ceftriaxone research is multidisciplinary, incorporating perspectives in Ciprofloxacin and Escherichia coli. His Drug resistance study frequently draws connections between adjacent fields such as Veterinary medicine.

Between 2011 and 2016, his most popular works were:

  • "Down the drain": carbapenem-resistant bacteria in intensive care unit patients and handwashing sinks (90 citations)
  • Genetic and Biochemical Characterization of an Acquired Subgroup B3 Metallo-β-Lactamase Gene, blaAIM-1, and Its Unique Genetic Context in Pseudomonas aeruginosa from Australia (61 citations)
  • Biotin analogues with antibacterial activity are potent inhibitors of biotin protein ligase. (29 citations)

In his most recent research, the most cited papers focused on:

  • Bacteria
  • Antibiotics
  • Gene

The scientist’s investigation covers issues in Microbiology, Staphylococcus aureus, Polymerase chain reaction, Disc diameter and Penicillin. His work in the fields of Microbiology, such as Cefepime, intersects with other areas such as Context. The various areas that Jan M. Bell examines in his Staphylococcus aureus study include DNA ligase, Enzyme inhibitor, Enzyme, Mode of action and Biotin.

His Polymerase chain reaction study combines topics from a wide range of disciplines, such as Genotyping, Locus, Multilocus sequence typing and DNA sequencing. Jan M. Bell integrates many fields, such as Disc diameter and engineering, in his works.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Survey of Infections Due to Staphylococcus Species: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999

D. J. Diekema;M. A. Pfaller;F. J. Schmitz;J. Smayevsky.
Clinical Infectious Diseases (2001)

1894 Citations

Dissemination of New Methicillin-Resistant Staphylococcus aureus Clones in the Community

Keiko Okuma;Kozue Iwakawa;John D. Turnidge;Warren B. Grubb.
Journal of Clinical Microbiology (2002)

1257 Citations

Early Dissemination of NDM-1- and OXA-181-Producing Enterobacteriaceae in Indian Hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 2006-2007

Mariana Castanheira;Lalitagauri M. Deshpande;Dilip Mathai;Jan M. Bell.
Antimicrobial Agents and Chemotherapy (2011)

468 Citations

Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR.

Benjamin P Howden;Christopher R E McEvoy;David L Allen;Kyra Y L Chua;Kyra Y L Chua.
PLOS Pathogens (2011)

306 Citations

Emergence of Vancomycin-Resistant Enterococci in Australia: Phenotypic and Genotypic Characteristics of Isolates

Jan M. Bell;James C. Paton;John Turnidge.
Journal of Clinical Microbiology (1998)

283 Citations

Dissemination of the Metallo-β-Lactamase Gene blaIMP-4 among Gram-Negative Pathogens in a Clinical Setting in Australia

Anton Y. Peleg;Clare Franklin;Jan M. Bell;Denis W. Spelman.
Clinical Infectious Diseases (2005)

256 Citations

Genetic Characterization of vanG, a Novel Vancomycin Resistance Locus of Enterococcus faecalis

Stuart J. McKessar;Anne M. Berry;Jan M. Bell;John D. Turnidge.
Antimicrobial Agents and Chemotherapy (2000)

249 Citations

Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002).

Yoichi Hirakata;Junichi Matsuda;Yoshitsugu Miyazaki;Shimeru Kamihira.
Diagnostic Microbiology and Infectious Disease (2005)

229 Citations

Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program.

Rodrigo E Mendes;Jan M Bell;John D Turnidge;John D Turnidge;Mariana Castanheira.
Journal of Antimicrobial Chemotherapy (2008)

219 Citations

In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae

Anima Poudyal;Benjamin P. Howden;Jan M. Bell;Jan M. Bell;Wei Gao.
Journal of Antimicrobial Chemotherapy (2008)

204 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jan M. Bell

Geoffrey W. Coombs

Geoffrey W. Coombs

Fiona Stanley Hospital

Publications: 99

Ronald N. Jones

Ronald N. Jones

JMI Laboratories

Publications: 73

Benjamin P. Howden

Benjamin P. Howden

University of Melbourne

Publications: 71

David L. Paterson

David L. Paterson

University of Queensland

Publications: 67

Timothy P. Stinear

Timothy P. Stinear

University of Melbourne

Publications: 55

Hermínia de Lencastre

Hermínia de Lencastre

Rockefeller University

Publications: 52

Patrice Nordmann

Patrice Nordmann

University of Fribourg

Publications: 49

Laurent Poirel

Laurent Poirel

University of Fribourg

Publications: 49

Roger L. Nation

Roger L. Nation

Monash University

Publications: 46

Helio S. Sader

Helio S. Sader

JMI Laboratories

Publications: 46

Keiichi Hiramatsu

Keiichi Hiramatsu

Juntendo University

Publications: 45

Graeme R. Nimmo

Graeme R. Nimmo

Griffith University

Publications: 42

Robert A. Bonomo

Robert A. Bonomo

Case Western Reserve University

Publications: 33

Paul D R Johnson

Paul D R Johnson

Austin Health

Publications: 30

Rodrigo E. Mendes

Rodrigo E. Mendes

JMI Laboratories

Publications: 29

Po-Ren Hsueh

Po-Ren Hsueh

China Medical University

Publications: 29

Trending Scientists

Beatrice Pesquet-Popescu

Beatrice Pesquet-Popescu

University of Paris-Saclay

Fredi Tröltzsch

Fredi Tröltzsch

Technical University of Berlin

Shaofan Li

Shaofan Li

University of California, Berkeley

Kinya Sakanishi

Kinya Sakanishi

National Institute of Advanced Industrial Science and Technology

Dominique Stoppa-Lyonnet

Dominique Stoppa-Lyonnet

Institute Curie

Nadav Shashar

Nadav Shashar

Ben-Gurion University of the Negev

Xiaoming Zou

Xiaoming Zou

University of Puerto Rico

Jorgina Satrústegui

Jorgina Satrústegui

Spanish National Research Council

Christopher S. Meinen

Christopher S. Meinen

Atlantic Oceanographic and Meteorological Laboratory

Sandro M. Radicella

Sandro M. Radicella

International Centre for Theoretical Physics

Klaus G. Reymann

Klaus G. Reymann

Leibniz Institute for Neurobiology

David F. Hultsch

David F. Hultsch

University of Victoria

Marley W. Watkins

Marley W. Watkins

Baylor University

Philip N. Hawkins

Philip N. Hawkins

The Royal Free Hospital

Denton A. Cooley

Denton A. Cooley

Texas Medical Center

Nestor F. Gonzalez-Cadavid

Nestor F. Gonzalez-Cadavid

University of California, Los Angeles

Something went wrong. Please try again later.